RAMAZZOTTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.987
AS - Asia 4.097
EU - Europa 3.711
AF - Africa 375
SA - Sud America 220
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.408
Nazione #
US - Stati Uniti d'America 4.919
SG - Singapore 1.264
IT - Italia 1.096
VN - Vietnam 1.026
CN - Cina 989
GB - Regno Unito 620
DE - Germania 485
SE - Svezia 448
HK - Hong Kong 243
FR - Francia 195
IN - India 172
RU - Federazione Russa 168
BR - Brasile 144
UA - Ucraina 114
IE - Irlanda 113
TG - Togo 109
KR - Corea 102
NL - Olanda 92
FI - Finlandia 81
CI - Costa d'Avorio 76
ZA - Sudafrica 67
JP - Giappone 63
SC - Seychelles 56
CA - Canada 46
CH - Svizzera 44
EE - Estonia 41
BG - Bulgaria 40
AT - Austria 39
NG - Nigeria 38
AR - Argentina 31
HR - Croazia 31
BD - Bangladesh 29
PK - Pakistan 27
BE - Belgio 24
ID - Indonesia 24
PH - Filippine 23
PL - Polonia 22
JO - Giordania 21
TH - Thailandia 18
IQ - Iraq 16
GR - Grecia 13
RO - Romania 12
TR - Turchia 12
MX - Messico 11
ES - Italia 10
TW - Taiwan 10
UY - Uruguay 10
MY - Malesia 8
UZ - Uzbekistan 8
AU - Australia 7
CO - Colombia 7
EC - Ecuador 7
CL - Cile 6
SA - Arabia Saudita 6
NZ - Nuova Zelanda 5
PE - Perù 5
TN - Tunisia 5
VE - Venezuela 5
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
MD - Moldavia 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
JM - Giamaica 3
LT - Lituania 3
MA - Marocco 3
PS - Palestinian Territory 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IR - Iran 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SS - ???statistics.table.value.countryCode.SS??? 2
SV - El Salvador 2
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 13.398
Città #
Singapore 892
Ashburn 534
Southend 519
Chandler 429
Fairfield 427
Bologna 357
Santa Clara 256
San Jose 253
Houston 238
Hong Kong 228
Ho Chi Minh City 226
Hanoi 197
Woodbridge 185
Ann Arbor 184
Hefei 180
Seattle 177
Cambridge 157
Wilmington 157
Boardman 139
Princeton 138
Beijing 130
Dallas 116
Dublin 114
Lomé 109
Dong Ket 102
New York 78
Abidjan 76
Frankfurt am Main 71
Seoul 69
Lauterbourg 68
Jacksonville 63
Milan 57
Westminster 56
Helsinki 53
Los Angeles 53
Nanjing 53
Tokyo 50
Padova 49
Council Bluffs 46
Berlin 45
Sofia 40
Munich 38
San Diego 38
Bern 37
Florence 36
Abeokuta 35
Buffalo 35
Moscow 33
Turin 33
Jinan 32
Saint Petersburg 32
Haiphong 29
Parma 29
Redondo Beach 29
São Paulo 29
Guangzhou 28
Rome 28
Da Nang 26
Vienna 26
Changsha 25
Redwood City 25
Johannesburg 24
Redmond 24
Shenyang 24
Brussels 23
Bremen 22
Des Moines 22
Shanghai 22
San Francisco 21
Amman 20
London 20
Sejong 18
Chicago 17
Medford 16
Nanchang 16
Orem 16
Udine 16
Toronto 15
Warsaw 15
Bengaluru 14
Jakarta 14
Lappeenranta 14
Turku 14
Zhengzhou 14
Kunming 13
Rimini 13
Tianjin 13
Biên Hòa 12
Nuremberg 12
Paris 12
The Dalles 12
Atlanta 11
Hangzhou 11
Hebei 11
Mountain View 11
Dearborn 10
Falkenstein 10
Montreal 10
Mülheim 10
Rawalpindi 10
Totale 8.596
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 354
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 293
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 255
Inositide-Dependent Nuclear Signalling in Health and Disease 251
Cancer therapy and treatments during COVID-19 era 243
A role for PKCepsilon during C2C12 myogenic differentiation 241
K562 cell proliferation is modulated by PLCbeta1 through a PKCalpha-mediated pathway 236
BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation 225
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 225
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 222
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 215
Nuclear inositide signaling and cell cycle 213
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 213
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 210
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 210
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 207
Nuclear Inositide Signaling via Phospholipase C 206
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 205
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 204
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. 203
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 202
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 201
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 199
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. 198
Revisiting nuclear phospholipase C signalling in MDS 195
Genotype of inflammatory cytokines in limbal stem cell graft in Italian patients. 194
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 194
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 193
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 188
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 187
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 187
Inositide signaling in the nucleus: From physiology to pathology. 185
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 185
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 184
Advances in MDS/AML and inositide signalling 183
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 183
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells 183
Physiology and pathology of nuclear phospholipase C beta1 182
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 180
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. 180
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C βI 179
Lamin B1 as a key modulator of the developing and aging brain 176
MiRNA-210: A Current Overview 176
Nuclear phospholipase C beta1 and cellular differentiation. 175
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 175
Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C 171
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions 169
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 168
Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula 167
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 165
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 163
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 162
PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells 161
Modulation of nuclear PI-PLCbeta1 during cell differentiation 156
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 154
The physiology and pathology of inositide signaling in the nucleus 153
Understanding the Ultra-Rare Disease Autosomal Dominant Leukodystrophy: an Updated Review on Morpho-Functional Alterations Found in Experimental Models 152
Nuclear inositide signaling in myelodysplastic syndromes. 151
A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression 150
Recent advances in MDS mutation landscape: Splicing and signalling 150
Nuclear PI-PLCbeta1-Lamin B1 complex signalling during cell cycle progression in human erytholeukemia cells 149
Nuclear translocation of PKCα isoenzyme is involved in neurogenic commitment of human neural crest-derived periodontal ligament stem cells 149
Role of nuclear PLC and PI3K signaling in the development of cancer 146
null 144
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression 143
Nuclear PI-PLC β1 and Myelodysplastic Syndromes: From Bench to Clinics 141
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 139
Nuclear PLCs affect insulin secretion by targeting PPARgamma; in pancreatic beta cells. 123
IPMK and β-catenin take part in PLC-β1-dependent signaling pathway during myogenic differentiation 116
Roles of p53, NF-kappa B and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 101
Nuclear phosphoinositides: location, regulation and function. 90
Phosphatidylinositol Turnover and Receptors 82
null 80
null 78
Inositide-dependent signal transduction in the nucleus: a virtuous path from the laboratory to the clinic 75
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells 73
Nuclear phospholipase C in biological control and cancer 69
null 65
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. 53
Totale 13.703
Categoria #
all - tutte 36.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021279 0 0 0 0 0 0 0 0 0 0 0 279
2021/20221.581 155 35 109 113 133 70 42 99 46 262 266 251
2022/20231.798 199 243 106 254 151 133 119 85 258 32 105 113
2023/2024658 26 91 83 64 69 105 40 31 32 38 31 48
2024/20252.034 87 253 209 127 336 108 188 97 49 112 106 362
2025/20264.499 385 495 424 302 559 250 490 133 850 291 173 147
Totale 13.703